Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
A cheerful multiracial group of happy friends in the park having fun.
The guideline is guided by the WHO’s vision of a world in which all people attain the highest possible level of health and well-being, leaving no one behind.
iStock, Jose carlos Cerdeno

WHO Extends Deadline for Trans People Health Guideline Feedback

The WHO aims to improve trans and gender-diverse people’s access to quality health care

World Health Organization
Published:Jan 15, 2024
|2 min read
Register for free to listen to this article
Listen with Speechify

The World Health Organization (WHO) Departments of Gender, Rights and Equity (GRE), Global HIV, Hepatitis and Sexually Transmitted Infections Programmes (HHS), and Sexual and Reproductive Health and Research (SRH) are in the process of developing a guideline on the health of trans and gender-diverse people—specifically, adults. 

A Guideline Development Group (GDG) has been established in line with standard procedures and the proposed composition of the GDG and related biographies were posted on the WHO website for general feedback on 28 June and 18 December 2023. The WHO received a spectrum of feedback from communities and stakeholders and appreciates the engagement seen to date. Acknowledging the need for more time for feedback, the WHO is extending the deadline for submissions until 2 February 2024.

that negatively impact the rights of trans and gender-diverse people to access quality health services, undermining their quality of life and life expectancy.

What will the guideline focus on?

This new guideline will focus on five areas:

  1. Provision of gender-affirming care, including hormones relating to adults.
  2. Health worker education on and training for the provision of gender-inclusive care.
  3. Provision of health care for trans and gender-diverse people who have suffered interpersonal violence, based on their needs.
  4. Health policies that support gender-inclusive care.
  5. Legal recognition of self-determined gender identity for adults.  

The GDG members include researchers with relevant technical expertise, end-users (e.g. program managers and health workers), and representatives of trans and gender-diverse community organizations, among others.

The members come from all six WHO regions, will act in their capacity (not representing any organization with which they are affiliated), and will not receive any financial compensation as per standard procedures.

- This press release was originally published on the World Health Organization website